Recurrent and disseminated pityriasis versicolor: A novel clinical form consequent to Malassezia-host interaction?

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
CHURCHILL LIVINGSTONE
Citação
MEDICAL HYPOTHESES, v.109, p.139-144, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Pityriasis versicolor is a superficial fungal infection caused by Malassezia spp. The aim of this study is to propose the definition of a new clinical entity: the recurrent and disseminated pityriasis versicolor (RDPV). All patients with RDPV were enrolled over an eight-month period. Clinical and epidemiological data were obtained, Malassezia (M.) species were isolated in cultures and identified by phenotypic and molecular characterization, skin biopsies were taken from active lesions, serum levels of immunoglobulin E were obtained and therapeutic schemes were evaluated. A total of 16 patients were included (11 male, 5 female). The most frequently isolated species were M. japonica (n = 3) and M. furfur (n = 3). This is the first study that isolates M. japonica in patients with pityriasis versicolor; interestingly, those were recalcitrant patients. Seven patients (43.8%) had no cure with any of the proposed treatments; among those, 5 (71.4%) had increased serum IgE levels. The most effective treatment was itraconazole 200 mg daily for 28 days. The RDPV has very different features from the classic form, including a poor response to treatment, and the isolation of different Malassezia species; therefore, we propose a hypothesis for the definition of a new clinical condition (RDPV), which could be a result of the interaction Malassezia-host.
Palavras-chave
Pityriasis versicolor, Recurrent, Disseminated, Malassezia, Immunology
Referências
  1. Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002
  2. Belem LF LE, 2001, BRASIL REV BRAS ANAL, P63
  3. Ben Salah S, 2005, MYCOSES, V48, P242
  4. Bhogal CS, 2001, J DERMATOL, V28, P535, DOI 10.1111/j.1346-8138.2001.tb00026.x
  5. BRASCH J, 1993, CLIN EXP DERMATOL, V18, P329, DOI 10.1111/j.1365-2230.1993.tb02209.x
  6. Casadevall A, 1998, MED MYCOL, V36, P95
  7. CHETTY GN, 1979, MYKOSEN, V22, P234
  8. Crespo Erchiga Vicente, 1999, Revista Iberoamericana de Micologia, V16, pS16
  9. Criado PR, 2011, AN BRAS DERMATOL, V86, P726, DOI 10.1590/S0365-05962011000400015
  10. de Oliveira CB, 2015, REV INST MED TROP SP, V57, P57, DOI 10.1590/S0036-46652015000100008
  11. Framil VMD, 2010, AN BRAS DERMATOL, V85, P111, DOI 10.1590/S0365-05962010000100021
  12. Framil VMD, 2011, AN BRAS DERMATOL, V86, P1135, DOI 10.1590/S0365-05962011000600011
  13. El-Gothamy Z, 1975, Int J Dermatol, V14, P510, DOI 10.1111/j.1365-4362.1975.tb04289.x
  14. FAERGEMANN J, 1979, ARCH DERMATOL, V115, P966, DOI 10.1001/archderm.115.8.966
  15. Farshchian M, 2002, J DERMATOL TREAT, V13, P73, DOI 10.1080/095466302317584421
  16. Furtado MSS CA, 1997, AN BRAS DERMATOL, P349
  17. Gaitanis G, 2006, BRIT J DERMATOL, V154, P854, DOI 10.1111/j.1365-2133.2005.07114.x
  18. Gaitanis G, 2009, CURR OPIN INFECT DIS, V22, P119, DOI 10.1097/QCO.0b013e328324ed19
  19. Galvis-Marfn JC, 2017, REV IBEROAM MICOL
  20. Giusiano G, 2010, REV IBEROAM MICOL, V27, P71, DOI 10.1016/j.riam.2009.12.005
  21. Guillot J, 1997, RES VET SCI, V62, P22, DOI 10.1016/S0034-5288(97)90174-0
  22. Gupta AK, 2014, J CUTAN MED SURG, V18, P79, DOI 10.2310/7750.2013.13062
  23. Gupta AK, 2004, J CLIN MICROBIOL, V42, P4253, DOI 10.1128/JCM.42.9.4253-4260.2004
  24. Gupta AK, 2002, J EUR ACAD DERMATOL, V16, P19, DOI 10.1046/j.1468-3083.2002.00378.x
  25. Gupta AK, 2001, MED MYCOL, V39, P199
  26. He SM, 2008, MYCOSES, V51, P55, DOI 10.1111/j.1439-0507.2007.01437.x
  27. Hong YJ, 2010, EXP DERMATOL, V19, P593
  28. Honnavar P, 2015, J MED MICROBIOL, V64, P232, DOI 10.1099/jmm.0.000011
  29. Hu SW, 2010, ARCH DERMATOL, V146, P1132, DOI 10.1001/archdermatol.2010.259
  30. Ishibashi Yoshio, 2009, Nihon Ishinkin Gakkai Zasshi, V50, P147
  31. Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008
  32. Krisanty RIA, 2009, MYCOSES, V52, P257, DOI 10.1111/j.1439-0507.2008.01593.x
  33. KROGER S, 1995, ACTA DERM-VENEREOL, V75, P357
  34. Lian CH, 2014, MYCOSES, V57, P759, DOI 10.1111/myc.12229
  35. Miranda KC, 2006, REV SOC BRAS MED TRO, V39, P582, DOI 10.1590/S0037-86822006000600017
  36. Morais Patricia Motta de, 2010, An Bras Dermatol, V85, P797
  37. Mostafa WZ, 2013, J AM ACAD DERMATOL, V69, pE19, DOI 10.1016/j.jaad.2012.03.004
  38. Oliveira JAA BJ, 2006, AN BRAS DERMATOL, P238
  39. Ponnighaus JM, 1996, MYCOSES, V39, P467
  40. Prohic A, 2016, INT J DERMATOL, V55, P494, DOI 10.1111/ijd.13116
  41. Rasi A, 2010, MYCOSES, V53, P350, DOI 10.1111/j.1439-0507.2009.01727.x
  42. Rojas FD, 2014, MED MYCOL, V52, P641, DOI 10.1093/mmy/myu010
  43. Romano C, 2013, REV IBEROAM MICOL, V30, P231, DOI 10.1016/j.riam.2013.02.001
  44. Rudramurthy SM, 2014, MYCOSES, V57, P483, DOI 10.1111/myc.12186
  45. Sancak Banu, 2005, Mikrobiyoloji Bulteni, V39, P301
  46. Sugita T, 2003, J CLIN MICROBIOL, V41, P4695, DOI 10.1128/JCM.41.10.4695-4699.2003
  47. SVEJGAARD E, 1985, ACTA DERM-VENEREOL, P72
  48. Tarazooie Bita, 2004, BMC Dermatol, V4, P5, DOI 10.1186/1471-5945-4-5
  49. Zawar V, 2009, J EUR ACAD DERMATOL, V23, P171, DOI 10.1111/j.1468-3083.2008.02750.x